|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000036952 |
|
Date of registration:
|
04/06/2019 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
A PET study with 18F-FDOPA and 11C-Raclopride on Parkinson's disease and related disorders patients.
|
|
Scientific title:
|
A PET study with 18F-FDOPA and 11C-Raclopride on Parkinson's disease and related disorders patients. - A PET study with 18F-FDOPA and 11C-Raclopride on Parkinson's disease and related disorders patients. |
|
Date of first enrolment:
|
2019/06/04 |
|
Target sample size:
|
150 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042101 |
|
Study type:
|
Interventional |
|
Study design:
|
Single arm Non-randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Yoshihiko
Horimoto |
|
Address:
|
1-2 Mikanyama, Yatomi-cho, Mizuho-ku, Nagoya, Japan
Japan |
|
Telephone:
|
052-835-3811 |
|
Email:
|
holly@nagoya-rehab.or.jp |
|
Affiliation:
|
Nagoya City Rehabilitation Agency Department of Neurology |
|
|
Name:
|
Yoshihiko
Horimoto |
|
Address:
|
1-2 Mikanyama, Yatomi-cho, Mizuho-ku, Nagoya, Japan
4678622
Japan |
|
Telephone:
|
052-835-3811 |
|
Email:
|
holly@nagoya-rehab.or.jp |
|
Affiliation:
|
Nagoya City Rehabilitation Agency Department of Neurology |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Patients having history of seizure, alcoholism, or any kind of drug dependency. Patients recognized to be inappropriate by anyone of attending physicians or study staffs.
Age minimum:
20years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Patients who are suspected Parkinson's disease or related disorders, including dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, frontotemporal lobe degeneration, vascular parkinsonism, drug-induced parkinsonism, normal pressure hydrocephalus, and others.
|
|
Intervention(s)
|
|
18F-FDOPA, 11C-Raclopride PET
|
|
Primary Outcome(s)
|
|
Comparison of conditions of dopamine metabolism and D2 receptor function among disorders.
|
|
Secondary Outcome(s)
|
|
Relationship between clinical pictures and conditions of dopamine metabolism or D2 receptor function.
|
|
Source(s) of Monetary Support
|
|
Nagoya City Rehabilitation Agency
|
|
Ethics review
|
Status: YES
Approval date: 29/05/2019
Contact:
soumubu@nagoya-rehab.or.jp
Nagoya City Rehabilitation Agency
052-835-3811
soumubu@nagoya-rehab.or.jp
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
31/03/2025 |
|
URL:
|
|
|
|